Complications of MRI-guided stereotactic biopsy of brain lymphoma

Hana Malikova1, Roman Liscak2, Iva Latnerova1

  • 1Department of Radiology, Na Homolce Hospital, Prague, Czech Republic.

Abstract

Insights

MRI-guided stereotactic biopsy is a safe and essential diagnostic tool for brain lymphoma, with a 92% diagnostic yield. However, patients with a history of lymphoma treatment face a higher risk of complications, including mortality from hemorrhage.

Area of Science:

  • Neurology
  • Neurosurgery
  • Oncology

Background:

  • Stereotactic biopsy is a standard procedure for diagnosing intrinsic brain lesions.
  • While generally safe, stereotactic biopsy carries inherent risks of complications.

Purpose of the Study:

  • To evaluate the morbidity and mortality associated with MRI-guided stereotactic biopsy.
  • To assess the safety and efficacy of this procedure specifically for brain lymphoma diagnosis.

Main Methods:

  • Retrospective analysis of medical records from January 2007 to December 2012.
  • Inclusion of 45 patients (27 males, 18 females) diagnosed with brain lymphoma via stereotactic biopsy.
  • Average of 3 tissue specimens collected per biopsy.

Main Results:

  • A diagnostic yield of 92% was achieved.
  • Overall major morbidity was 6.1% (3 cases), with a 4.1% mortality rate (2 cases).
  • Deaths were attributed to intracranial hemorrhage; complications were higher in previously treated lymphoma patients.

Conclusions:

  • Stereotactic biopsy remains a crucial diagnostic method for primary brain lymphomas.
  • The procedure offers an acceptable risk profile for initial diagnosis.
  • Previously treated patients with secondary brain lymphomas may experience increased complication risks.

Related Concept Videos